FILLING MATERIALS
Discover our different biomaterial solutions (sponges, powders, syringes) that allow us to recreate sufficient bone volume by compensating for insufficient thickness or height.
XENOGRAFT: COLLAGEN + HYDROXYAPATITE
COLLAPAT® II
COLLAPAT® II SPONGE HAEMOSTATIC BONE SUBSTITUTE
COLLAPAT® II consists of a collagen support which contains ceramic hydroxypatite granules. The hydroxypatite granules give the material its osteoconductive properties. Hydroxypatite is the highest mineral component in enamel, dentine and mineralised bone. It reabsorbs slowly. The collagen gives COLLAPAT® II its haemostatic power and is completely reabsorbed in a few weeks. The collagen is extracted from bovine hide.
THE SYMATESE TECHNOLOGICAL COLLAGEN PLATFORM GIVES COLLAPAT® II ITS FEATURES
An alternative to autologous or allogeneic grafts
COLLAPAT® II offers immediate availability and unlimited product quantity unlike autologous bone to avoid comorbidities
The unique cross-linking process maintains the collagen structure while the patient’s cells colonise the graft. Collagen reabsorption is involved in bone replacement
The collagen gives COLLAPAT® II its haemostatic power and is completely reabsorbed in a few weeks
The three-dimensional, porous mineral structure of COLLAPAT® II improves osteoblast differentiation and speeds up osteogenesis on the entire grafted area
COLLAPAT® II is osteoconductive, and colonised by healthy bone tissue through intensive regeneration
Manufacturer: SYMATESE
Distributed by: BIOTECH DENTAL – 305, Allées de Craponne – 13300 Salon de Provence – France. simplified company limited by shares with a capital of €24,866,417 – trade and companies register of Salon de Provence, France: 795 001 304 – SIRET number [French business registration number]: 795 001 304 00018 – VAT No.: FR 31 79 500 13 04.For health professionals only. The COLLAPAT® II bone implant is a Class III implantable medical device marked CE0459. Images for illustration purposes only. These medical devices are regulated health products that carry the CE mark.
SYNTHETIC
Guidor® easy-graft
The advantage of manipulation
Synthetic bone substitutes
• CLASSIC+ – 100% resorption, more space for new bone
• CLASSIC+ consists of pure phase ß-TCP. The resorption of the material takes place in parallel with the regeneration of the bone.
• CLASSIC+ offers complete resorption in 5 to 15 months. In clinical practice, resorption of ß-TCP is observed after shorter periods of healing. No residual material remains.
• CRYSTAL+ – Partial resorption, integration into the bone
• CRYSTAL+ is made of biphasic calcium phosphate (BCP) consisting of 60% hydroxyapatite HA and 40% ß-TCP. The BCP serves as a stable scaffold for long-term volume preservation and the HA is integrated into the newly formed bone.
In situ hardening malleable synthetic bone substitute that can be applied directly from the syringe
Malleability when coming out of the syringe
In situ hardening
Manufacturer: Degradable Solutions AG. Class III medical devices for dental surgery reserved for health professionals. CE0297. Carefully read the instructions in the leaflets/brochures. Biotech Dental – simplified company limited by shares with a capital of €24,866,417 – trade and companies register of Salon de Provence, France: 795 001 304 – SIRET number [French business registration number]: 795 001 304 00018 – VAT No.: FR 31 79 500 13 04
